Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing Anticalin class of biotherapeutics for patients with diseases in which there is high unmet medical needs.
$1.57 +0.01 (0.64%)
As of 08/12/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.